|
1
|
Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer.
|
Gynecol Oncol
|
2012
|
2.01
|
|
2
|
Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?
|
Am J Obstet Gynecol
|
2000
|
1.93
|
|
3
|
Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?
|
J Clin Oncol
|
1999
|
1.69
|
|
4
|
Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
|
Mod Pathol
|
1996
|
1.51
|
|
5
|
Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma.
|
Gynecol Oncol
|
2000
|
1.43
|
|
6
|
Primary ovarian carcinoid tumors.
|
Gynecol Oncol
|
1996
|
1.26
|
|
7
|
Aggressive angiomyxoma of the female pelvis and perineum: a case series.
|
Int J Gynecol Cancer
|
2006
|
1.26
|
|
8
|
Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading.
|
J Neuropathol Exp Neurol
|
2001
|
1.25
|
|
9
|
Serous borderline tumor of the paratestis: a report of seven cases.
|
Am J Surg Pathol
|
2001
|
1.25
|
|
10
|
Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
|
Cancer Res
|
1994
|
1.18
|
|
11
|
Solitary fibrous tumor: a study of cytologic features of six cases diagnosed by fine-needle aspiration.
|
Diagn Cytopathol
|
2001
|
1.18
|
|
12
|
Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome.
|
Gynecol Oncol
|
1994
|
1.18
|
|
13
|
Deciduoid peritoneal mesothelioma. An unusual phenotype affecting young females.
|
Am J Surg Pathol
|
1994
|
1.16
|
|
14
|
HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer.
|
Br J Cancer
|
2008
|
1.14
|
|
15
|
Intracardiac leiomyomatosis: echocardiographic features.
|
Chest
|
1999
|
1.13
|
|
16
|
Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis.
|
Gynecol Oncol
|
2000
|
1.13
|
|
17
|
HER-2/neu expression: a major prognostic factor in endometrial cancer.
|
Gynecol Oncol
|
1992
|
1.11
|
|
18
|
Hematogenous dissemination in corpus cancer.
|
Gynecol Oncol
|
2001
|
1.10
|
|
19
|
Prognostic significance of p53 immunostaining in epithelial ovarian cancer.
|
J Clin Oncol
|
1994
|
1.10
|
|
20
|
Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer.
|
Gynecol Oncol
|
2001
|
1.08
|
|
21
|
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
|
Cancer Res
|
1993
|
1.08
|
|
22
|
Female urethral adenocarcinoma: immunohistochemical evidence of more than 1 tissue of origin.
|
J Urol
|
1999
|
1.00
|
|
23
|
The epidemiology of ovarian cancer: a population-based study in Olmsted County, Minnesota, 1935-1991.
|
Ann Epidemiol
|
2000
|
0.95
|
|
24
|
Renal plasmacytoma: Mayo Clinic experience and review of the literature.
|
Urology
|
1991
|
0.95
|
|
25
|
Female urethral adenocarcinoma: evidence for more than one tissue of origin?
|
Gynecol Oncol
|
1995
|
0.94
|
|
26
|
Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer.
|
Gynecol Oncol
|
2013
|
0.93
|
|
27
|
Benign tumors of the breast with multinucleated stromal giant cells. Immunohistochemical analysis of six cases and review of the literature.
|
Virchows Arch
|
2001
|
0.92
|
|
28
|
Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.
|
Am J Pathol
|
1993
|
0.88
|
|
29
|
Skene's gland adenocarcinoma with increased serum level of prostate-specific antigen.
|
Gynecol Oncol
|
1994
|
0.87
|
|
30
|
Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy.
|
Cancer
|
1990
|
0.87
|
|
31
|
Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer.
|
Gynecol Oncol
|
2013
|
0.87
|
|
32
|
Pretreatment assessment of prognostic indicators in endometrial cancer.
|
Am J Obstet Gynecol
|
2000
|
0.86
|
|
33
|
Multifocal malignant melanoma arising in vesicovaginal melanosis.
|
Arch Pathol Lab Med
|
1991
|
0.86
|
|
34
|
Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.
|
Gynecol Oncol
|
2001
|
0.84
|
|
35
|
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
|
Bone Marrow Transplant
|
2009
|
0.84
|
|
36
|
Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma.
|
Gynecol Oncol
|
1996
|
0.82
|
|
37
|
c-erbB-2 and p53 expression in fallopian tube carcinoma.
|
Cancer
|
1995
|
0.82
|
|
38
|
Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors.
|
Am J Clin Pathol
|
1994
|
0.82
|
|
39
|
Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survival.
|
Am J Obstet Gynecol
|
1996
|
0.81
|
|
40
|
Subungual keratoacanthoma. Report of a case and review of the literature.
|
Arch Dermatol
|
1988
|
0.81
|
|
41
|
Lipoblastoma-like tumour of the vulva: report of three cases of a distinctive mesenchymal neoplasm of adipocytic differentiation.
|
Histopathology
|
2002
|
0.80
|
|
42
|
Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survival.
|
Gynecol Oncol
|
1992
|
0.80
|
|
43
|
Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma.
|
Gynecol Oncol
|
1992
|
0.79
|
|
44
|
Overexpression of p34cdc2 protein kinase in epithelial ovarian carcinoma.
|
Mayo Clin Proc
|
1997
|
0.79
|
|
45
|
Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
|
Gynecol Oncol
|
1996
|
0.78
|
|
46
|
Referral and ascertainment bias in patients with synchronous and metachronous endometrial malignancy.
|
Eur J Gynaecol Oncol
|
2010
|
0.77
|
|
47
|
Endometrial cancer in Olmsted County, MN: trends in incidence, risk factors and survival.
|
Ann Epidemiol
|
2000
|
0.77
|
|
48
|
Telomerase activity in sex cord-stromal tumors of the ovary.
|
Gynecol Oncol
|
2001
|
0.77
|
|
49
|
Assessment of inhibin and p53 in granulosa cell tumors of the ovary.
|
Gynecol Oncol
|
2000
|
0.77
|
|
50
|
The proto-oncogene c-fms is overexpressed in endometrial cancer.
|
Gynecol Oncol
|
1993
|
0.77
|
|
51
|
Polymorphous hemangioendothelioma: a report of two cases, one affecting extranodal soft tissues, and review of the literature.
|
Am J Surg Pathol
|
1997
|
0.75
|
|
52
|
Preoperative serum level of inhibin A is an independent prognostic factor for the survival of postmenopausal women with epithelial ovarian carcinoma.
|
Cancer
|
1999
|
0.75
|
|
53
|
Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study.
|
Gynecol Oncol
|
2011
|
0.75
|
|
54
|
Paget's disease of the groin: report of seven cases.
|
Plast Reconstr Surg
|
1997
|
0.75
|
|
55
|
Primary malignant fibrous histiocytoma of the pleura. A case report and review of the literature.
|
Respir Med
|
1994
|
0.75
|
|
56
|
Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma.
|
Gynecol Oncol
|
1997
|
0.75
|
|
57
|
Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
|
Gynecol Oncol
|
1999
|
0.75
|
|
58
|
DNA index by flow cytometric analysis: an additional prognostic factor in advanced ovarian carcinoma without residual disease after primary operation.
|
Gynecol Oncol
|
1996
|
0.75
|
|
59
|
Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
|
Gynecol Oncol
|
1999
|
0.75
|
|
60
|
Health careers--exploding myths.
|
Health Educ
|
1990
|
0.75
|
|
61
|
Concordance of DNA ploidy pattern as measured by flow cytometry in primary, metastatic, and persistent ovarian carcinoma.
|
Gynecol Oncol
|
1996
|
0.75
|
|
62
|
Internationalizing college health education courses. Selected teaching strategies.
|
Health Educ
|
1990
|
0.75
|
|
63
|
Red cell fragmentation in human disease (a light and scanning electron microscope study).
|
Blood Cells
|
1984
|
0.75
|